| Primary |
| Rheumatoid Arthritis |
71.8% |
| Drug Use For Unknown Indication |
5.2% |
| Hypertension |
3.9% |
| Osteoporosis |
2.7% |
| Product Used For Unknown Indication |
2.4% |
| Arthritis |
2.2% |
| Prophylaxis |
2.2% |
| Polyarthritis |
1.6% |
| Pain |
1.3% |
| Psoriatic Arthropathy |
1.2% |
| Gastritis |
1.0% |
| Diabetes Mellitus |
0.7% |
| Hypothyroidism |
0.7% |
| Depression |
0.5% |
| Prophylaxis Against Gastrointestinal Ulcer |
0.5% |
| Osteoporosis Prophylaxis |
0.5% |
| Gastric Ulcer |
0.4% |
| Contraception |
0.4% |
| Drug Detoxification |
0.4% |
| Vitamin Supplementation |
0.4% |
|
| Drug Exposure During Pregnancy |
31.3% |
| Maternal Exposure During Pregnancy |
8.8% |
| Weight Decreased |
8.2% |
| Vomiting |
6.9% |
| Exposure During Pregnancy |
5.3% |
| Transaminases Increased |
4.4% |
| Liver Function Test Abnormal |
4.1% |
| Pyrexia |
3.0% |
| Rash |
2.9% |
| Pregnancy |
2.6% |
| Aspartate Aminotransferase Increased |
2.5% |
| White Blood Cell Count Decreased |
2.5% |
| Hepatic Enzyme Increased |
2.4% |
| Transmission Of Drug Via Semen |
2.4% |
| Death |
2.3% |
| Myocardial Infarction |
2.2% |
| Hepatic Function Abnormal |
2.1% |
| Pneumonia |
2.0% |
| Sepsis |
2.0% |
| Drug Exposure Before Pregnancy |
1.9% |
|
| Secondary |
| Rheumatoid Arthritis |
58.2% |
| Product Used For Unknown Indication |
10.7% |
| Hypertension |
5.4% |
| Drug Use For Unknown Indication |
4.6% |
| Osteoporosis |
4.0% |
| Pain |
3.0% |
| Prophylaxis |
1.8% |
| Behcet's Syndrome |
1.3% |
| Psoriatic Arthropathy |
1.2% |
| Anaesthesia |
1.1% |
| Osteoporosis Prophylaxis |
1.1% |
| Depression |
1.0% |
| Prophylaxis Against Gastrointestinal Ulcer |
1.0% |
| Juvenile Arthritis |
0.9% |
| Arthritis |
0.9% |
| Asthma |
0.8% |
| Diabetes Mellitus |
0.7% |
| Gastritis |
0.7% |
| Inflammation |
0.7% |
| Hypercholesterolaemia |
0.7% |
|
| Vomiting |
9.8% |
| Weight Decreased |
8.9% |
| Liver Function Test Abnormal |
6.1% |
| White Blood Cell Count Decreased |
5.9% |
| Pyrexia |
5.7% |
| Rheumatoid Arthritis |
5.5% |
| Rash |
5.2% |
| Ureteric Stenosis |
5.2% |
| Pneumonia |
4.8% |
| Renal Failure |
4.8% |
| Drug Exposure During Pregnancy |
4.5% |
| Alanine Aminotransferase Increased |
4.3% |
| Aspartate Aminotransferase Increased |
4.3% |
| Hepatic Enzyme Increased |
4.1% |
| Maternal Exposure During Pregnancy |
4.1% |
| Diarrhoea |
3.6% |
| Hepatic Function Abnormal |
3.6% |
| Uterine Cancer |
3.4% |
| Upper Respiratory Tract Infection |
3.2% |
| Thrombocytopenia |
3.0% |
|
| Concomitant |
| Rheumatoid Arthritis |
44.8% |
| Product Used For Unknown Indication |
21.6% |
| Drug Use For Unknown Indication |
9.0% |
| Hypertension |
5.0% |
| Osteoporosis |
2.9% |
| Psoriatic Arthropathy |
2.6% |
| Pain |
2.5% |
| Arthritis |
2.0% |
| Diabetes Mellitus |
1.2% |
| Prophylaxis |
0.9% |
| Premedication |
0.9% |
| Asthma |
0.9% |
| Depression |
0.9% |
| Vitamin Supplementation |
0.9% |
| Hypothyroidism |
0.8% |
| Ankylosing Spondylitis |
0.8% |
| Blood Cholesterol Increased |
0.6% |
| Hormone Replacement Therapy |
0.6% |
| Cardiac Disorder |
0.6% |
| Gastrooesophageal Reflux Disease |
0.6% |
|
| Injection Site Pain |
11.9% |
| Rheumatoid Arthritis |
10.3% |
| Weight Decreased |
7.2% |
| Pain |
5.8% |
| Vomiting |
5.5% |
| Pain In Extremity |
5.4% |
| Injection Site Reaction |
4.9% |
| Sinusitis |
4.9% |
| Pneumonia |
4.8% |
| Weight Increased |
4.7% |
| Urinary Tract Infection |
4.5% |
| Drug Ineffective |
4.1% |
| Injection Site Swelling |
3.7% |
| Nausea |
3.6% |
| Pyrexia |
3.6% |
| Arthralgia |
3.2% |
| Rash |
3.1% |
| Nasopharyngitis |
3.0% |
| Psoriasis |
2.9% |
| Urticaria |
2.9% |
|
| Interacting |
| Rheumatoid Arthritis |
48.0% |
| Drug Use For Unknown Indication |
13.0% |
| Osteoporosis |
9.8% |
| Polyarthritis |
7.3% |
| Prophylaxis |
4.1% |
| Hypertension |
3.3% |
| Product Used For Unknown Indication |
2.4% |
| Hypertonic Bladder |
1.6% |
| Osteoporotic Fracture |
1.6% |
| Pain |
1.6% |
| Prophylaxis Against Gastrointestinal Ulcer |
1.6% |
| Tuberculin Test Positive |
1.6% |
| Contraception |
0.8% |
| Diabetes Mellitus |
0.8% |
| Hypercholesterolaemia |
0.8% |
| Infection |
0.8% |
| Peptic Ulcer |
0.8% |
|
| Renal Failure |
14.3% |
| Neutropenia |
10.7% |
| Drug Interaction |
7.1% |
| Myocardial Infarction |
7.1% |
| Pancytopenia |
7.1% |
| Polyneuropathy |
7.1% |
| Pyrexia |
7.1% |
| Vocal Cord Disorder |
7.1% |
| White Blood Cell Count Decreased |
7.1% |
| Drug Exposure During Pregnancy |
3.6% |
| Interstitial Lung Disease |
3.6% |
| Lentigo Maligna Stage Unspecified |
3.6% |
| Polyp |
3.6% |
| Pulmonary Embolism |
3.6% |
| Red Blood Cell Count Decreased |
3.6% |
| Skin Exfoliation |
3.6% |
|
